1 We have compared the antagonist activity of trinitrophenyl-ATP (TNP-ATP) and diinosine pentaphosphate (Ip 5 I) on recombinant P2X receptors expressed in Xenopus oocytes with their actions at native P2X receptors in sensory neurones from dorsal root and nodose ganglia. 2 Slowly-desensitizing responses to a,b-methylene ATP (a,b-meATP) recorded from oocytes expressing P2X 2/3 receptors were inhibited by TNP-ATP at sub-micromolar concentrations. However, Ip 5 I at concentrations up to 30 mM was without eect. 3 Nodose ganglion neurones responded to a,b-meATP with slowly-desensitizing inward currents. These were inhibited by TNP-ATP (IC 50 , 20 nM), but not by Ip 5 I at concentrations up to 30 mM. 4 In DRG neurones that responded to ATP with a rapidly-desensitizing inward current, the response was inhibited by TNP-ATP with an IC 50 of 0.8 nM. These responses were also inhibited by Ip 5 I with an IC 50 of 0.1 mM. Both antagonists are known to inhibit homomeric P2X 3 receptors. 5 Some DRG neurones responded to a,b-meATP with a biphasic inward current, consisting of transient and sustained components. While the transient current was abolished by 1 mM Ip 5 I, the sustained component remained unaected. 6 In conclusion, Ip 5 I is a potent antagonist at homomeric P2X 3 receptors but not at heteromeric P2X 2/3 receptors, and therefore should be a useful tool for elucidating the subunit composition of native P2X receptors.
Introduction
ATP can excite sensory neurones from dorsal root and nodose ganglia as well as neurones in the dorsal horn of the spinal cord (Jahr & Jessel, 1983; Krishtal et al., 1983) . Furthermore, when ATP is injected intradermally, it causes intense pain, thus suggesting a role for ATP in nociception and primary aerent neurotransmission (for review see Burnstock & Wood, 1996; Burnstock, 2000) . Immunohistochemical and in situ hybridization studies indicate that of the seven P2X subunits cloned, P2X 1 ± P2X 6 are expressed in sensory ganglia (Chen et al., 1995; Collo et al., 1996; Vulchanova et al., 1997; Xiang et al., 1998) . Functional studies in vitro so far suggest that it is the P2X 2 and P2X 3 subunits that are important for the activation of primary aerents by ATP Robertson et al., 1996; Cook et al., 1997) . However, the lack of suitable pharmacological tools has so far prevented the characterization of P2X receptors on sensory neurones in vivo.
P2X receptors are oligomeric complexes of uncertain stoichiometry, but possibly composed of either three subunits (Nicke et al., 1998; Stoop et al., 1999) or four subunits (Kim et al., 1997; Ding & Sachs, 2000) . In sensory neurones, the expression of P2X 2 and P2X 3 subunits can give rise to the formation of both homomeric P2X 2 and P2X 3 receptors as well as at least one population of heteromeric P2X 2/3 receptors Thomas et al., 1998; Grubb & Evans, 1999) .
The development of more selective agonists and antagonists will help to clarify the involvement of dierent subunits in the formation of native P2X receptors and the role of these dierent receptors in physiological and pathophysiological processes.
Diinosine pentaphosphate (Ip 5 I) is a very potent antagonist at recombinant P2X 1 receptors (pA 2 , 8.2) and is quite active at P2X 3 receptors with a pA 2 of 6.3 (King et al., 1999) . In this study, we have investigated the antagonist activity of Ip 5 I at the recombinant heteromeric P2X 2/3 receptor. We have then compared it with trinitrophenyl-ATP (TNP-ATP) as an antagonist at the rapidly-desensitizing P2X receptors present on dorsal root ganglion (DRG) neurones and the slowlydesensitizing a, b-meATP sensitive receptor present on nodose ganglion neurones. While the former are believed to be homomeric P2X 3 (Robertson et al., 1996; Cook et al., 1997) , the latter are thought to be heteromeric P2X 2/3 receptors .
Methods

Native receptors in sensory neurones
Dissociated sensory neurones were prepared following a protocol used previously for isolation of autonomic ganglion neurones (Zhong et al., 1998) . Rat pups (0 ± 2-days-old) were killed by cervical dislocation followed by decapitation. Dorsal root or nodose ganglia were removed and placed in Ca 2+ / Mg 2+ free Hanks' Balanced Salt Solution containing 10 mM HEPES (pH 7.3) buer (HBSS). Ganglia were treated with collagenase 1.5 mg ml 71 (CLS II; Worthington Biochemical Corporation, Reading, U.K.) for 40 min, followed by trypsin 1 mg ml 71 (Sigma) for 15 min. The ganglia were then suspended in growth medium comprising of L-15 medium (Gibco) supplemented with 10% bovine serum albumin, 2 mg ml 71 NaHCO 3 , 5.5 mg ml Figure 1 Comparison of the action of TNP-ATP and Ip 5 I on recombinant P2X 2 , P2X 3 and P2X 2/3 receptors. (a) Response of three dierent Xenopus oocytes expressing P2X 3 , P2X 2 and P2X 2/3 receptors, to ATP or a,b-meATP alone, and in the presence of 30 mM diinosine pentaphosphate (Ip 5 I). (b) Concentration-eect curves for the inhibition of P2X 3 , P2X 2 and P2X 2/3 receptors by Ip 5 I. ATP was used as the agonist at 3 mM and 10 mM for P2X 3 and P2X 2 receptors respectively, while 1 mM a,b-meATP was used in experiments on the heteromeric receptor. Points represent the mean+s.e.mean from ®ve cells. Antagonists were given for 60 s before, and during the agonist application. In the presence of Ip 5 I, the peak amplitude of agonist evoked responses at P2X 2 and P2X 2/3 receptors were not signi®cantly dierent from control (P40.05). (c) Responses to a,b-meATP recorded from an oocyte expressing P2X 2/3 receptors in the presence of increasing concentrations of TNP-ATP. Comparable results were obtained in a further three cells. Oocytes were voltage-clamped at a holding potential of 750 mV. Antagonists were present for 60 s before and during the agonist applications. In oocytes co-injected with P2X 2 and P2X 3 transcripts, the transient current due to activation of homomeric P2X 3 receptors was abolished by a condition application of a,b-meATP (10 mM, 20 s) given 60 s before the test response, leaving only the sustained response mediated by P2X 2/3 receptors.
harvested by centrifugation at 900 r.p.m. for 5 min. The resultant pellet was re-suspended in growth medium and plated onto 35 mm culture dishes that had been pre-treated with 10 mg ml 71 laminin (Sigma). Cells were maintained at 378C in a humidi®ed atmosphere containing 5% CO 2 , and used between 2 and 10 h after plating.
Whole cell voltage-clamp recording was carried out at room temperature using an Axopatch 200B ampli®er (Axon Instruments, Foster City, CA, U.S.A.). Membrane potential was held at 770 mV. External solution contained (mM): NaCl 154, KCl 4.7, MgCl 2 1.2, CaCl 2 2.5, HEPES 10, Glucose 5.6, the pH was adjusted to 7.4 using NaOH. Recording electrodes (resistance 2 ± 4 MO) were ®lled with internal solution that contained (mM): CsCl 120, HEPES 10, tripotassium citrate 10, the pH was adjusted to 7.2 using CsOH. Data were acquired using pCLAMP software (Axon Instruments). Signals were ®ltered at 2 kHz (73 dB frequency, Bessel ®lter, 80 dB/ decade).
Drugs were applied rapidly through a 4-barrel manifold comprising fused glass capillaries inserted into a common outlet tube (tip diameter of *200 mm) which was placed about 200 mm from the cell (Dunn et al., 1996) . Solutions were delivered by gravity¯ow from independent reservoirs with solution¯ow controlled by computer driven solenoid valves. One barrel was used to apply drug free solution to enable rapid termination of drug application. Solution exchange measured by the change in open tip current on switching from 150 mM NaCl to 150 mM KCl solution was complete in 20 ms; however, complete exchange of solution around an intact cell was considerably slower (4100 ms). Traces were acquired using Fetchex (pCLAMP software) and plotted using Origin (Microcal, Northampton, MA, U.S.A.).
Recombinant receptors expressed in Xenopus oocytes
Methods for preparation of defolliculated oocytes from Xenopus laevis have been described in detail previously (King et al., 1997b) . Defolliculated oocytes were injected (40 nl) cytosolically with capped ribose nucleic acid (cRNA) encoding either rat P2X 2 or rat P2X 3 receptors. In coexpression experiments, oocytes were injected with a mixture of cRNAs prepared by mixing rP2X 2 cRNA (2 mg ml 71 ) with rP2X 3 cRNA (1 mg ml 71 ), yielding a concentration ratio of 1 : 500. RNA-injected oocytes were incubated at 188C in Barth's solution (pH 7.5) containing (mM): NaCl 110, KCl 1, NaHCO 3 2.4, Tris-HCl 7.5, Ca(NO 3 ) 2 0.33, CaCl 2 0.41, MgSO 4 0.82, supplemented with gentamycin sulphate 50 mg l 71 for 48 h to allow full receptor expression and then stored at 48C for up to 12 days.
Membrane currents were recorded under voltage-clamp conditions using a twin-electrode ampli®er (Axoclamp 2B). The microelectrodes had a resistance of 1 ± 2 MO when ®lled with 3 M KCl. Oocytes were perfused constantly (at 5 ml min
71
) with Ringer's solution containing (mM): NaCl 110, KCl 2.5, HEPES 5, BaCl 2 1.8, pH 7.5. All recordings were made at room temperature (188C) and at a holding potential of 750 mV unless stated otherwise. Electrophysiological data were recorded on a chart recorder (Gould recorder 2200s).
Solutions were delivered by gravity¯ow from independent reservoirs placed above the preparation. Applications of agonists were separated by a 20 min interval unless otherwise stated. The P2 receptor antagonists TNP-ATP (3 ± 1000 nM) and Ip 5 I (0.03 ± 100 mM) were applied for 1 min prior to and during agonist application. For concentration-inhibition curves, data were normalized with respect to the response evoked in the absence of antagonist.
Data analysis
All data are expressed as the means+s.e.mean. Statistical analysis (Student's t-test) was performed using Origin 5 (Microcal, Northampton, MA, U.S.A.); P values 50.05 were considered signi®cant. Concentration-response data were ®tted with the Hill equation: Y=A/[1+(K/X) n ], where: A is the maximum eect, K is the EC 50 , and n is the Hill coecient, using Origin 5. The combined data from the given number of cells were ®tted, and the results are presented as values+s.e., determined by the ®tting routine.
Drugs and reagents
All common salts were AnalaR grade (BDH, Lutterworth, U.K.). Diinosine pentaphosphate (Ip 5 I) was prepared by enzymatic degradation of diadenosine pentaphosphate (Ap 5 A) (see King et al., 1999) . Trinitrophenyl-ATP (Molecular Probes, Leiden, Netherlands). All other drugs were from Sigma Chemical Co (Poole, Dorset, U.K.).
Results
Recombinant receptors expressed on Xenopus oocytes
Oocytes injected with P2X 3 cRNA responded to ATP (3 mM) with a rapidly-desensitizing inward current (Figure 1a ). Micromolar concentrations of Ip 5 I produced a concentration dependent inhibition of this response (Figure 1a,b) , which is in keeping with the previously published IC 50 of 2.8+0.7 mM (King et al., 1999) . In contrast, oocytes injected with P2X 2 cRNA gave a slowly-desensitizing response to ATP that was not aected by Ip 5 I at concentrations up to 30 mM ( Figure  1a,b) . In oocytes co-injected with P2X 2 and P2X 3 cRNA, it was necessary to use a,b-meATP as the agonist, to prevent activation of homomeric P2X 2 receptors. Nevertheless, a,b- Selective antagonism of P2X 3 receptors by Ip 5 ImeATP evoked a biphasic response (see Figure 2) that we attribute to the activation of homomeric P2X 3 and heteromeric P2X 2/3 receptors (n=8). By using a pre-application of 10 mM a,b-meATP to produce selective desensitization of the P2X 3 receptors, the heteromeric receptor could be studied in isolation. Ip 5 I at concentrations up to 30 mM produced no inhibition of the slowly-desensitizing response to 1 mM a,bmeATP (Figure 1a,b) . In contrast, sub-micromolar concentrations of TNP-ATP (0.01 ± 0.1 mM) produced a concentration dependent reduction in the response to a,b-meATP ( Figure  1c) , consistent with the previously published IC 50 of 7 nM . Similar results were obtained in all four oocytes tested. We next investigated the eect of these two antagonists on co-injected oocytes, without prior desensitization of the P2X 3 receptors. Under these conditions a,b-meATP evoked a biphasic response composed of transient and sustained inward currents. TNP-ATP produced a concentration dependent reduction in both the transient and sustained parts of the response (Figure 2a) . In contrast, Ip 5 I selectively 
Native receptors in nodose ganglion neurones
In agreement with the observations of Khakh and colleagues (1995) , all neurones dissociated from neonatal rat nodose ganglia responded to 10 mM a,b-meATP with a rapidlyactivating and slowly-desensitizing response (Figure 3a) attributed to the activation of heteromeric P2X 2/3 receptors. These neurones posses both homomeric P2X 2 and heteromeric P2X 2/3 receptors (Thomas et al., 1998) , so a,b-meATP was used as the agonist to avoid activation of homomeric P2X 2 receptors. Transient responses to a,b-meATP are not evoked in these neurones, indicating the absence of homomeric P2X 3 receptors. Consequently, the desensitizing pre-pulse used in the oocyte experiments was not necessary. TNP-ATP produced a concentration dependent inhibition of this response with an IC 50 of 20.5+2.8 nM (Figure 3c ). We investigated further the antagonism produced by TNP-ATP, by looking at its action on the a,b-meATP log-concentration-response curve. In the presence of 0.1 mM TNP-ATP, a concentration that we had found to reduce the response to 10 mM a,b-meATP by about 75%, there was a rightward shift in the a,b-meATP logconcentration-response curve, increasing the EC 50 from 39 ± 167 mM (Figure 4a ). However, there was also a marked reduction in the slope of the curve, suggesting that TNP-ATP does not act as a simple competitive antagonist. In contrast, Ip 5 I at concentrations up to 30 mM failed to produce any antagonism of the a,b-meATP response in nodose ganglion neurones (Figure 3d ).
Native receptors in DRG neurones
DRG neurones can respond to ATP with either rapidlydesensitizing, sustained, or biphasic responses (Robertson et al., 1996; Burgard et al., 1999; Grubb & Evans, 1999) . In our experiments, approximately 50% (105/209) of dissociated DRG neurones, responded to 10 mM ATP with only a fast activating and rapidly-desensitizing inward current. This response declined to less than 10% of the peak by the end of a 1 s agonist application and is believed to be mediated by homomeric P2X 3 receptors (Figure 3b ). TNP-ATP produced a rapid and reversible inhibition of this response. The eect of TNP-ATP was concentration dependent with an IC 50 of 0.77+0.12 nM (Figure 3c ). Ip 5 I also produced a reversible, concentration dependent inhibition of the transient ATP response in DRG neurones, with an IC 50 of 0.12+0.03 mM (Figure 3d) . We investigated the nature of the antagonism produced by Ip 5 I, by examining its eect on the ATP logconcentration response curve. In the presence of 0.3 mM Ip 5 I, a concentration predicted to give approximately 75% inhibition, the maximum response to ATP was greatly reduced, while the EC 50 was almost unchanged (2.3 mM compared with 2.1 mM; Figure 4b) .
A small percentage of DRG neurones responded to a,bmeATP with a clearly biphasic inward current, consisting of both transient and sustained components, similar to those observed in co-injected oocytes. In four such cells where the current at 1 s was 36+6% of the peak current, 1 mM Ip 5 I, abolished the transient component, while leaving the sustained current unaected (Figure 5 ).
Discussion
Ip 5 I is an antagonist at recombinant P2X 1 and P2X 3 receptors, but is ineective at P2X 2 receptors (King et al., 1999) . We have now extended these studies, and found that this compound is also ineective as an antagonist at the heteromeric P2X 2/3 receptor. It thus shows at least 100 fold selectivity for P2X 3 over P2X 2/3 receptors. In contrast, although TNP-ATP is much more potent than Ip 5 I as an antagonist at P2X 3 receptors, it is also very active at heteromeric P2X 2/3 receptors, with at best a 10 fold selectivity between these receptor sub-types .
It has been suggested that the rapidly-desensitizing ATP responses in sensory neurones are due to activation of homomeric P2X 3 receptors (Robertson et al., 1996 , Cook et al., 1997 . In contrast, the slowly-desensitizing a,b-meATP sensitive receptor found in nodose ganglion cells results from the activation of heteromeric P2X 2/3 receptors . In keeping with this view, we have not only con®rmed that the rapidly-desensitizing receptor is blocked by nanomolar concentrations of TNP-ATP, but we have also demonstrated its sensitivity to Ip 5 I. In contrast, the slowlydesensitizing response to a,b-meATP in nodose ganglion neurones is not aected by Ip 5 I at concentrations up to 30 mM (the highest concentration tested). This is in keeping with our observation that the recombinant P2X 2/3 receptor is resistant to Ip 5 I.
In dissociated neurones, responses mediated by homomeric P2X 3 receptors can readily be distinguished from those of heteromeric P2X 2/3 receptors by their time course. However in multicellular preparations and in vivo, this distinction may be less clear (see Kirkup et al., 1999; Rong et al., 2000) . In such situation, an antagonist like Ip 5 I should be very useful in identifying the type of P2X receptor involved.
The nature of the antagonism produced by TNP-ATP and Ip 5 I appear to be complex. Thus, at the recombinant P2X 3 receptor, TNP-ATP produces a non-surmountable antagonism . Such behaviour may in part result from the very rapid desensitization of this receptor, which will prevent equilibrium being established between the receptor, agonist and antagonist. The antagonism at the P2X 2/3 receptor in nodose ganglion neurones produced by 0.1 mM TNP-ATP appeared to be surmountable, although there was a reduction in the slope of the log-concentration-response curve indicating a non-competitive interaction. At recombinant P2X 1 and P2X 3 receptors low concentrations of Ip 5 I produce parallel shifts in the agonist log-concentration response curves, but the antagonism was found to be non-competitive (King et al, 1999) . Our experiments investigating the antagonism of the native P2X receptor in DRG neurones by Ip 5 I showed a nonsurmountable, non-competitive antagonism. However, the very rapid desensitization of this response prevents true equilibrium being established and may again complicate interpretation of the results. The rapid desensitization of P2X 3 and P2X 1 receptors is determined by the intracellular domains (Werner et al., 1996; King et al., 1997a; Smith et al., 1999) . It would therefore be interesting to see how TNP-ATP and Ip 5 I interact with chimeric receptors possessing the extracellular loop of the P2X 3 receptor and the cytoplasmic and trans-membrane segments of the P2X 2 receptor. Such receptors should retain the pharmacology of the P2X 3 receptor, but with the slow desensitization of the P2X 2 receptor.
Our results on the action of TNP-ATP and Ip 5 I at recombinant P2X receptors expressed in Xenopus oocytes, are in broad agreement with our results on the native receptors found in sensory neurones (Table 1) . However, the results are not identical. In particular, Ip 5 I produces a non-surmountable antagonism of the rapidly-desensitizing receptor in DRG neurones and it is considerably more potent than at the recombinant P2X 3 receptor. The reason for this is at present unclear, but receptors expressed in Xenopus oocytes do show some dierences from those expressed in mammalian cells (Evans et al., 1995; Lewis et al., 1997 ). An alternative, though perhaps less likely explanation is that the rapidly-desensitizing receptor present on DRG neurones is not in fact a homomeric P2X 3 receptor, but incorporates some additional subunit(s). However in general, our results thus support the notion that the slowly-desensitizing a,b-meATP response in nodose ganglion neurones is mediated by heteromeric P2X 2/3 receptors, while the rapidly-desensitizing response seen in DRG neurones is mediated by homomeric P2X 3 receptors.
In conclusion, we have demonstrated that Ip 5 I is an eective antagonist of the homomeric P2X 3 with an IC 50 of 3 mM, but is inactive at the heteromeric P2X 2/3 receptor. The ability of Ip 5 I to discriminate between the rapidly-desensitizing responses in DRG neurones and the slowly-desensitizing a,b-meATP response in nodose ganglion neurones supports the notion that these responses are mediated by P2X 3 and P2X 2/3 receptors respectively. Ip 5 I should be a useful tool for further elucidating the subunit composition of native P2X receptors.
